Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, ACC

Hansa Biopharma announces participation in Fall conferences and an updated financial calendar


LUND, Sweden, Aug. 31, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will present at the following upcoming investor conferences in September:           

A link to the presentations and webcasts will be available on the Events & Presentations page of the Company's website at http://www.hansabiopharma.com.

Calendar

Aug 31,2020    Kempen Road Show, Tel Aviv/Paris/Benelux (virtual)
Sep 3, 2020     Pareto Healthcare Conference, Stockholm (virtual)
Sep 9, 2020     Citibank's Annual BioPharma Virtual Conference, Boston (virtual)
Sep 15, 2020   H.C. Wainwright Healthcare Conference, NYC (virtual)
Sep 16, 2020   Bank of America Merill Lynch Healthcare Conf., London (virtual)
Sep 18, 2020   MorganStanley Global Healthcare Conference, NYC (virtual)
Sep 23, 2020   ABG Small & Mid Cap Seminar, Copenhagen and virtual
Oct 22, 2020   Interim Report Jan-Sep 2020
Oct 29, 2020   Hansa Biopharma Capital Markets Day, Copenhagen and virtual
Nov 17, 2020   Bryan Garnier Healthcare Conference, Paris
Nov 18, 2020   Jefferies Healthcare Conference, London
Nov 25, 2020   Ökonomisk Ugebrev Life Science Conference, Copenhagen
Feb 2, 2021     Interim report for Jan - Dec 2020
April 8, 2021    Annual Report 2020
April 22, 2021   Interim report for Jan - Mar 2021
July 15, 2021    Interim report for Jan - Jun 2021
Oct 21, 2021    Interim report for Jan - Sep 2021

CONTACT:

For further information, please contact:
Klaus Sindahl, Head of Investor Relations
Hansa Biopharma 
Mobile: +46 (0) 709-298 269
E-mail: [email protected]  

Katja Margell
Head of Corporate Communications 
Hansa Biopharma 
Mobile: +46 (0) 768-198 326
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-announces-participation-in-fall-conferences-and-an-updated-financial-calendar,c3182962

The following files are available for download:

https://mb.cision.com/Main/1219/3182962/1298637.pdf

Release

 

SOURCE Hansa Biopharma AB


These press releases may also interest you

at 04:31
Aquaporin raises DKK 172 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance HealthCare Group expands luxury mental health and addiction services for UHNW individuals
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions and The Pathway join forces to elevate continuing education in restorative dentistry.
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
Enzymatica Interim report Q1/2024: MDR certification opens up great commercial opportunities
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
4 university colleges in Denmark join forces to enhance on-site and remote education for radiographers with Sectra Education Portal
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

More news about Health...


News published on and distributed by: